Pharma IQ will be
holding its 5th Annual Pharmaceutical & Biotech Patent Litigation
Strategies conference on May 24-26, 2010 in London, England.  The conference will allow attendees to:

• Protect a patent
portfolio through implementation of the best practice policy and efficient
management strategies;
• Discover the
intricate relationship between the EPO and the London Patents Court to
understand the affect it has on EPO decisions and Patent Court judgments;
• Defend a patent
portfolio against attack on the grounds of obviousness through strategies of
obviousness attacks and defense in the UK;
• Understand
preliminary injunctions to enable an efficient obtainment and explore important
recent case decisions; and
• Prepare for a
patent litigation in court by considering the European Court perspectives.

In particular, the
conference will offer presentations on the following topics:

• Patent litigation
from a practical corporate perspective: 
The internal and external organization need;
• Review of recent
European cases and decisions to understand and implement best practice
strategies for the future;
• International
patent litigation:  Do less, gain
more;
• An update on
current trends in patent litigation;
• A comparison of
biosimilars legislation and Hatch-Waxman Act procedures in the U.S.A.;
• Best practice
strategies to manage patent protection;
• Exploring the
application of Supplementary Protection Certificates (SPCs) to extend patent
life and in turn, maximize profit;
• Pro-competitive
aspects of patent settlements;
• P.I.T. STOP
1:  Panel discussion:  Exploring the implications of changes
to antitrust laws on patent litigation;
• From Pan-European
litigation to the Patents County Court;
• The view from the
Intellectual Property Office of the UK;
• Assessment of
inventive step in the UK;
• An overview of
preliminary injunctions in Denmark;
• The London
Patents Court v. the EPO;
• P.I.T. STOP:  The view of the Courts;
• The view of the
Courts:  Interactive panel
discussion; and
• The inequitable
conduct defense in U.S. patent litigation:  A shield, a sword, a scourge and a trap for the unwary.

The agenda for the
Pharmaceutical & Biotech Patent Litigation Strategies conference can be
found here (Day 1) and
here (Day 2).  A complete brochure for this
conference, including an agenda, list of speakers, and registration form can be
downloaded here.

Three
pre-conference workshops will be offered on May 24, 2010:

• The first workshop, entitled "The Best
Practice Strategies for Drafting and Litigating Your Patent," will be
offered from 9:00 to 11:30 am, and will allow attendees to understand the
evolving IP landscape in emerging markets in order to protect a patent
portfolio effectively, cover key factors that must be considered when
litigating in various countries, and provide examples of best practice
strategies from recent cases.
• The
second workshop, entitled "Protecting Your Product and Conducting Pre-suit
Investigations in the U.S.," will be offered from 12:00 to 2:30 pm, and
will provide a review of listing patents in the FDA Orange Book and using
different regulatory exclusivity periods to protect products in the U.S.,
methods for assessing the strength of a case in the face of generic challenge
in the U.S., and considerations regarding whether and where to file a
litigation in the U.S.
• The third
workshop, entitled "Review of Recent Case Law, Settlements, Competition
Law and Best Practice Strategies for Protecting a Patent Portfolio," will
be offered from 3:00 to 5:30 pm, and will provide a review of recent case law,
an overview of preliminary injunctions, how to protect against irreparable harm
and damages, an outlook to the future and foresight for the changing IP
landscape.

The registration
fees for the conference and focus day are as follows:  £499 (one workshop), £1,998 (conference and one workshop),
£2,497 (conference and two workshops), and £3,495 (conference and three
workshops).  Those registering on
or before April 16, 2010 will receive a discount of £100 (conference alone),
£200 (conference and one workshop), £300 (conference and two workshops), or
£400 (conference and three workshops) off the registration fee.  Those interested in registering for the
conference can do so here.

Patent Docs is a media partner of Pharma IQ's Pharmaceutical & Biotech Patent
Litigation Strategies conference.